Sebastian Stasik
Sebastian Stasik
Verified email at uniklinikum-dresden.de
Title
Cited by
Cited by
Year
Adaptation of the hydrocarbonoclastic bacterium Alcanivorax borkumensis SK2 to alkanes and toxic organic compounds: a physiological and transcriptomic approach
DJ Naether, S Slawtschew, S Stasik, M Engel, M Olzog, LY Wick, ...
Applied and environmental microbiology 79 (14), 4282-4293, 2013
702013
Understanding biogeochemical gradients of sulfur, iron and carbon in an oil sands tailings pond
S Stasik, N Loick, K Knöller, C Weisener, K Wendt-Potthoff
Chemical Geology 382, 44-53, 2014
432014
Anaerobic BTEX degradation in oil sands tailings ponds: impact of labile organic carbon and sulfate-reducing bacteria
S Stasik, LY Wick, K Wendt-Potthoff
Chemosphere 138, 133-139, 2015
352015
TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas: a pilot prospective study
TA Juratli, S Stasik, A Zolal, C Schuster, S Richter, D Daubner, MA Juratli, ...
Clinical Cancer Research 24 (21), 5282-5291, 2018
322018
Interaction of microbial sulphate reduction and methanogenesis in oil sands tailings ponds
S Stasik, K Wendt-Potthoff
Chemosphere 103, 59-66, 2014
302014
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer
S Stasik, K Salomo, U Heberling, M Froehner, U Sommer, GB Baretton, ...
Clinical biochemistry 64, 60-63, 2019
262019
An optimized targeted next-generation sequencing approach for sensitive detection of single nucleotide variants
S Stasik, C Schuster, C Ortlepp, U Platzbecker, M Bornhäuser, J Schetelig, ...
Biomolecular detection and quantification 15, 6-12, 2018
202018
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association
C Gebhard, D Glatz, L Schwarzfischer, J Wimmer, S Stasik, M Nuetzel, ...
Leukemia 33 (1), 26-36, 2019
162019
Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
AS Kubasch, F Schulze, A Giagounidis, KS Götze, J Krönke, K Sockel, ...
Leukemia 34 (4), 1182-1186, 2020
152020
Microbial communities in oil sands tailings: their implications in biogeochemical processes and tailings management
T Siddique, S Stasik, MF Mohamad Shahimin, K Wendt-Potthoff
Microbial communities utilizing hydrocarbons and lipids: members …, 2018
122018
Disposal of waste materials at the bottom of pit lakes
M Schultze, B Boehrer, K Friese, M Koschorreck, S Stasik, ...
Proceedings of the Sixth International Conference on Mine Closure, 555-564, 2011
112011
Differences between CEBPA bZIP and TAD mutations and their effect on outcome-an analysis in 4578 patients with acute myeloid leukemia
JA Georgi, F Taube, M Kramer, S Herold, K Schaefer-Eckart, N Schmitz, ...
Blood 128 (22), 283, 2016
82016
Clinical challenges and consequences of measurable residual disease in non-APL acute myeloid leukemia
M Jentzsch, S Schwind, E Bach, S Stasik, C Thiede, U Platzbecker
Cancers 11 (11), 1625, 2019
72019
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
AS Kubasch, R Wehner, S Bazzurri, A Tunger, S Stasik, M Garzarolli, ...
Blood advances 2 (11), 1187, 2018
72018
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
S Stasik, JM Middeke, M Kramer, C Röllig, A Krämer, S Scholl, ...
haematologica 105 (5), e228, 2020
62020
Use of minimal residual disease in acute myeloid leukemia therapy
S Schwind, M Jentzsch, E Bach, S Stasik, C Thiede, U Platzbecker
Current treatment options in oncology 21 (1), 1-13, 2020
62020
Vertical gradients in carbon flow and methane production in a sulfate-rich oil sands tailings pond
S Stasik, K Wendt-Potthoff
Water research 106, 223-231, 2016
52016
Clinical characteristics and outcome in IDH1/2 mutant AML patients-analysis of 3898 newly diagnosed patients with acute myeloid leukemia
JM Middeke, C Rollig, M Kramer, A Kramer, T Bochtler, S Scholl, ...
Blood 132, 1461, 2018
22018
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis
JM Middeke, R Teipel, C Röllig, S Stasik, A Zebisch, H Sill, M Kramer, ...
Leukemia & Lymphoma 62 (6), 1432-1440, 2021
12021
EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia
S Stasik, JM Middeke, M Kramer, C Rollig, A Krämer, S Scholl, ...
Blood 132, 1528, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20